The Lymphoma, Leukemia, and Myeloma Congress delivers comprehensive, evidence-based education across the full spectrum of hematologic malignancies. Through expert-driven sessions, case-based discussions, and analysis of the most recent clinical data, attendees gain clear, clinically relevant direction for optimizing patient management. The meeting brings together leading investigators and practicing clinicians to provide balanced perspectives that support informed, confident treatment decisions in rapidly evolving disease settings.

Key Features

LL&M Congress

Compared to Other Hematology Meetings

Scope of Curriculum Covers the full spectrum of hematologic malignancies, including leukemia, lymphoma, myeloma, and CLL, through in-depth sessions on emerging data, frontline and relapsed/refractory management, and evolving standards of care. Other meetings may be disease-specific or focus narrowly on one malignancy, offering less cross-disciplinary perspective.
Educational Format Features a blend of expert-led lectures, panel discussions, and case-based presentations that connect evidence with clinical application. Each session is designed to translate new data into actionable treatment strategies. Many meetings rely on traditional lecture-only formats, providing limited opportunity for clinical dialogue or multidimensional case exploration.
Faculty Expertise Led by internationally recognized investigators and clinicians who are directly involved in current trials and frontline patient care, offering balanced, practical insights. Some programs feature fewer practicing clinicians or a narrower range of expert voices.
Integration Within the LL&M Ecosystem Serves as the cornerstone of the LL&M educational series, linking to the LL&M Winter Symposium and APP Institute for continuous learning and consistent messaging throughout the year. Most hematology meetings function as standalone events, without connection to complementary or follow-up educational opportunities.
Audience Engagement Designed for clinical relevance and discussion, with opportunities to engage through Q&A, panel dialogue, and case review. The environment encourages participation and peer learning. Often passive learning environments, where attendees primarily listen to lectures with minimal engagement.
Community & Continuity Builds a loyal, collaborative community of oncologists, hematologists, and APPs who return annually to exchange insights and advance patient care across disease areas. Many conferences operate as one-off events, lacking the sense of continuity or professional network that LL&M fosters.
Practical Takeaways Every session focuses on translating data into practice, giving attendees concrete guidance for patient management, sequencing decisions, and incorporating new agents. Attendees at other meetings often receive broad data overviews without clear translation into real-world clinical workflows.
Back to top